Metastatic or Unresectable Cutaneous Melanoma
1 clinical trials · Condition
◉ Watch Metastatic or Unresectable Cutaneous Melanoma
| Record | Firm | Date |
|---|---|---|
| Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma (NCT01763164) | Pfizer | 2013-07-12 |
Track Metastatic or Unresectable Cutaneous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.